Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q1 2019 · 10-Q
Revenue$0.00$0.00no prior Q1 2018 on file Net Income-$1.33M-$1.33MN/M vs Q1 2018 EPS Diluted-$6.45-$6.45N/M vs Q1 2018 Operating Income-$1,327,155N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 13, 2019 · 43 d after period end